Compare Unichem Lab with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ALEMBIC PHARMA UNICHEM LAB/
ALEMBIC PHARMA
 
P/E (TTM) x -86.0 13.8 - View Chart
P/BV x 0.5 3.7 12.7% View Chart
Dividend Yield % 2.9 1.0 286.7%  

Financials

 UNICHEM LAB   ALEMBIC PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
ALEMBIC PHARMA
Mar-19
UNICHEM LAB/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs292664 44.0%   
Low Rs182412 44.1%   
Sales per share (Unadj.) Rs167.7208.7 80.3%  
Earnings per share (Unadj.) Rs-3.631.0 -11.7%  
Cash flow per share (Unadj.) Rs5.937.1 16.0%  
Dividends per share (Unadj.) Rs4.005.50 72.7%  
Dividend yield (eoy) %1.71.0 165.2%  
Book value per share (Unadj.) Rs372.3144.2 258.1%  
Shares outstanding (eoy) m70.38188.52 37.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.42.6 54.8%   
Avg P/E ratio x-65.317.4 -376.0%  
P/CF ratio (eoy) x39.914.5 275.0%  
Price / Book Value ratio x0.63.7 17.1%  
Dividend payout %-110.217.7 -620.9%   
Avg Mkt Cap Rs m16,680101,461 16.4%   
No. of employees `0002.6NA-   
Total wages/salary Rs m2,3937,467 32.1%   
Avg. sales/employee Rs Th4,535.2NM-  
Avg. wages/employee Rs Th919.8NM-  
Avg. net profit/employee Rs Th-98.2NM-  
INCOME DATA
Net Sales Rs m11,80139,347 30.0%  
Other income Rs m98494 1,049.1%   
Total revenues Rs m12,78539,441 32.4%   
Gross profit Rs m-8358,736 -9.6%  
Depreciation Rs m6741,152 58.5%   
Interest Rs m75184 40.8%   
Profit before tax Rs m-6007,493 -8.0%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m1-93 -0.8%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3431,568 -21.9%   
Profit after tax Rs m-2565,844 -4.4%  
Gross profit margin %-7.122.2 -31.9%  
Effective tax rate %57.320.9 273.8%   
Net profit margin %-2.214.9 -14.6%  
BALANCE SHEET DATA
Current assets Rs m20,38419,577 104.1%   
Current liabilities Rs m5,02914,896 33.8%   
Net working cap to sales %130.111.9 1,093.7%  
Current ratio x4.11.3 308.4%  
Inventory Days Days10590 116.7%  
Debtors Days Days13545 297.4%  
Net fixed assets Rs m9,02327,097 33.3%   
Share capital Rs m141377 37.3%   
"Free" reserves Rs m26,05826,811 97.2%   
Net worth Rs m26,19927,188 96.4%   
Long term debt Rs m04,993 0.0%   
Total assets Rs m31,49647,778 65.9%  
Interest coverage x-7.041.7 -16.7%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.40.8 45.5%   
Return on assets %-0.612.6 -4.5%  
Return on equity %-1.021.5 -4.5%  
Return on capital %-2.023.6 -8.5%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18819,453 42.1%   
Fx outflow Rs m5966,065 9.8%   
Net fx Rs m7,59213,388 56.7%   
CASH FLOW
From Operations Rs m-3,2788,120 -40.4%  
From Investments Rs m-2,860-7,556 37.9%  
From Financial Activity Rs m-24590 -4.1%  
Net Cashflow Rs m-4,6901,153 -406.7%  

Share Holding

Indian Promoters % 50.1 74.1 67.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 2.9 520.7%  
FIIs % 3.0 9.1 33.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 13.9 228.1%  
Shareholders   20,176 49,328 40.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   DIVIS LABORATORIES  SUN PHARMA  PIRAMAL ENTERPRISES  TTK HEALTHCARE  SHASUN PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 674 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day and ended lower. Investors were worried about the economic impact and uncertainty over the coronavirus pandemic.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

One Stock that is All Charged Up for the Post Coronavirus Rebound(The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Apr 3, 2020 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - SANOFI INDIA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS